Motion Perception in Individuals With Type 2 Diabetes
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 10/18/2018 |
| Start Date: | August 1, 2017 |
| End Date: | June 1, 2019 |
| Contact: | Faisal Karmali, PhD |
| Email: | faisal_karmali@meei.harvard.edu |
| Phone: | 4102187614 |
Vestibular Perception and Action
Is the ability to perceive motion altered by diabetes? The investigators are measuring motion
perception using a technique called vestibular thresholds. Subjects will undergo 3 hours of
testing in which they sit in a chair that makes small movements and report their perception
of motion. The investigators are currently looking for individuals who have had type 2
diabetes for at least 10 years.
perception using a technique called vestibular thresholds. Subjects will undergo 3 hours of
testing in which they sit in a chair that makes small movements and report their perception
of motion. The investigators are currently looking for individuals who have had type 2
diabetes for at least 10 years.
Previous studies have found that individuals with diabetes fall more frequently, have less
stable posture, and have reduced motion and touch sensation in the lower extremities. This
study will examine whether vestibular sensation is also affected by diabetes.
This study is observational because measurements will be made without the application of an
intervention. The same measurement protocol was applied to a large group of normal subjects,
and this published data will serve as normative controls.
stable posture, and have reduced motion and touch sensation in the lower extremities. This
study will examine whether vestibular sensation is also affected by diabetes.
This study is observational because measurements will be made without the application of an
intervention. The same measurement protocol was applied to a large group of normal subjects,
and this published data will serve as normative controls.
Inclusion Criteria:
- Type 2 diabetes for at least 10 years
- Under 250 pounds
Exclusion Criteria:
- Medications not to be used include: Ambien (Zolpidem), Antivert, Bonine (Meclizine),
Ativan (Lorazepam), Benadryl (diphenhydramine), Dalmane (Flurazepam), Dramamine, Doral
(Quazepam), Fiorinal, Fiorcet (Butalbital), Halcion (Triazolam), Klonopin
(Clonazepam), Librium, Librax (Chlordiazepoxide), Nembutal (Pentobarbital), Phenergan
(Promethazine), Placidyl (Ethchlorvynol), Prosom (Estazolam), Restoril (Temazepam),
Seconal (Secobarbital), Serax (Oxazepam), Transderm Scopes Patch, Vontrol
(Diphenidol), Xanax (Alprazolam).
- Individuals meeting the following criteria will be excluded: a) a history of head
trauma, b) posterior fossa pathology, c) a well-defined otologic diagnosis (e.g.,
Benign Paroxysmal Positional Vertigo (BPPV), Meniere's disease, superior canal
dehiscence, etc., unilateral or bilateral vestibular hypofunction) d) a recent history
of seizures e) any other major neurologic (e.g., Parkinson's, Multiple Sclerosis,
dementia, epilepsy, cerebellar ataxia, stroke, recent concussion, etc.) disorder, f)
any major psychiatric (e.g., panic disorder, psychosis, etc.) disorder, and g) any
other severe health problem (heart disease, pulmonary disease, cancer, etc.).
- Due to nauseogenic nature of some motions and to protect fetus and mother, pregnant
women will also be excluded from this study.
We found this trial at
1
site
243 Charles St
Boston, Massachusetts 02114
Boston, Massachusetts 02114
(617) 523-7900
Phone: 410-218-7614
Massachusetts Eye & Ear Infirmary Whether you see our physicians at Mass. Eye and Ear's...
Click here to add this to my saved trials
